Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Long-acting Reversible Contraceptives (LARCs) Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Long-acting Reversible Contraceptives (LARCs) Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Industry: Medical Devices & Consumables

Published: 2023-05-31

Pages: 116 Pages

Report ld: 1353800

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Long-acting Reversible Contraceptives (LARCs) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Long-acting Reversible Contraceptives (LARCs) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Age 20-24 and Age 25-34 are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Long-acting Reversible Contraceptives (LARCs) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.

Globally, Long-acting Reversible Contraceptives (LARCs) key manufacturers include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna and ASPIVIX, etc. Bayer, Merck, Cooper Companies are top 3 players and held % sales share in total in 2022.

Long-acting Reversible Contraceptives (LARCs) can be divided into Hormonal Intrauterine Devices, Copper Intrauterine Devices, Contraceptive Implants and Others, etc. Hormonal Intrauterine Devices is the mainstream product in the market, accounting for % sales share globally in 2022.

Long-acting Reversible Contraceptives (LARCs) is widely used in various fields, such as Age 20-24, Age 25-34, Age 35-44 and Others, etc. Age 20-24 provides greatest supports to the Long-acting Reversible Contraceptives (LARCs) industry development. In 2022, global % sales of Long-acting Reversible Contraceptives (LARCs) went into Age 20-24 filed. 
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Long-acting Reversible Contraceptives (LARCs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
    Bayer
    Merck
    Cooper Companies
    AbbVie Allergan
    Yantai JiShengYaoXie
    H & J Medical
    HRA Pharma
    Pregna
    ASPIVIX
    Shanghai Dahua Pharmaceuticals
    Williams Medical Supplies
    Laboratoire 7 MED
    Durbin
    Laboratoire CCD
    Prosan
    OCON

Segment by Type
    Hormonal Intrauterine Devices
    Copper Intrauterine Devices
    Contraceptive Implants
    Others

Segment by Application
    Age 20-24
    Age 25-34
    Age 35-44
    Others

Segment by Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E

Each chapter of the report provides detailed information for readers to understand the Long-acting Reversible Contraceptives (LARCs) market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Long-acting Reversible Contraceptives (LARCs), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Long-acting Reversible Contraceptives (LARCs) industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Long-acting Reversible Contraceptives (LARCs) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Long-acting Reversible Contraceptives (LARCs) introduction, etc. Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Long-acting Reversible Contraceptives (LARCs) market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Long-acting Reversible Contraceptives (LARCs) Market Overview
    1.1 Long-acting Reversible Contraceptives (LARCs) Product Overview
    1.2 Long-acting Reversible Contraceptives (LARCs) Market Segment by Type
        1.2.1 Hormonal Intrauterine Devices
        1.2.2 Copper Intrauterine Devices
        1.2.3 Contraceptive Implants
        1.2.4 Others
    1.3 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Type
        1.3.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Type (2018-2029)
        1.3.2 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2018-2023)

 2 Global Long-acting Reversible Contraceptives (LARCs) Market Competition by Company
    2.1 Global Top Players by Long-acting Reversible Contraceptives (LARCs) Sales (2018-2023)
    2.2 Global Top Players by Long-acting Reversible Contraceptives (LARCs) Revenue (2018-2023)
    2.3 Global Top Players by Long-acting Reversible Contraceptives (LARCs) Price (2018-2023)
    2.4 Global Top Manufacturers Long-acting Reversible Contraceptives (LARCs) Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Long-acting Reversible Contraceptives (LARCs) Market Competitive Situation and Trends
        2.5.1 Long-acting Reversible Contraceptives (LARCs) Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-acting Reversible Contraceptives (LARCs) as of 2022)
    2.7 Date of Key Manufacturers Enter into Long-acting Reversible Contraceptives (LARCs) Market
    2.8 Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Long-acting Reversible Contraceptives (LARCs) Status and Outlook by Region
    3.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Region
        3.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2018-2023)
        3.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales in Value by Region (2018-2023)
        3.2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Region
        3.3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2024-2029)
        3.3.2 Global Long-acting Reversible Contraceptives (LARCs) Sales in Value by Region (2024-2029)
        3.3.3 Global Long-acting Reversible Contraceptives (LARCs) Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Long-acting Reversible Contraceptives (LARCs) by Application
    4.1 Long-acting Reversible Contraceptives (LARCs) Market Segment by Application
        4.1.1 Age 20-24
        4.1.2 Age 25-34
        4.1.3 Age 35-44
        4.1.4 Others
    4.2 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Application
        4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Application (2018-2029)
        4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2018-2023)

 5 North America Long-acting Reversible Contraceptives (LARCs) by Country
    5.1 North America Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Country
        5.1.1 North America Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2018-2023)
        5.1.3 North America Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2018-2023)
    5.2 North America Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Country
        5.2.1 North America Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2024-2029)
        5.2.2 North America Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2024-2029)

 6 Europe Long-acting Reversible Contraceptives (LARCs) by Country
    6.1 Europe Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Country
        6.1.1 Europe Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2018-2023)
        6.1.3 Europe Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2018-2023)
    6.2 Europe Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Country
        6.2.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2024-2029)
        6.2.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2024-2029)

 7 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) by Region
    7.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Region
        7.1.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Region
        7.2.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales in Value by Region (2024-2029)

 8 Latin America Long-acting Reversible Contraceptives (LARCs) by Country
    8.1 Latin America Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Country
        8.1.1 Latin America Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2018-2023)
    8.2 Latin America Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Country
        8.2.1 Latin America Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2024-2029)

 9 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) by Country
    9.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Country
        9.1.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Country
        9.2.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 Bayer
        10.1.1 Bayer Company Information
        10.1.2 Bayer Introduction and Business Overview
        10.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.1.5 Bayer Recent Development
    10.2 Merck
        10.2.1 Merck Company Information
        10.2.2 Merck Introduction and Business Overview
        10.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.2.5 Merck Recent Development
    10.3 Cooper Companies
        10.3.1 Cooper Companies Company Information
        10.3.2 Cooper Companies Introduction and Business Overview
        10.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.3.5 Cooper Companies Recent Development
    10.4 AbbVie Allergan
        10.4.1 AbbVie Allergan Company Information
        10.4.2 AbbVie Allergan Introduction and Business Overview
        10.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.4.5 AbbVie Allergan Recent Development
    10.5 Yantai JiShengYaoXie
        10.5.1 Yantai JiShengYaoXie Company Information
        10.5.2 Yantai JiShengYaoXie Introduction and Business Overview
        10.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.5.5 Yantai JiShengYaoXie Recent Development
    10.6 H & J Medical
        10.6.1 H & J Medical Company Information
        10.6.2 H & J Medical Introduction and Business Overview
        10.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.6.5 H & J Medical Recent Development
    10.7 HRA Pharma
        10.7.1 HRA Pharma Company Information
        10.7.2 HRA Pharma Introduction and Business Overview
        10.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.7.5 HRA Pharma Recent Development
    10.8 Pregna
        10.8.1 Pregna Company Information
        10.8.2 Pregna Introduction and Business Overview
        10.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.8.5 Pregna Recent Development
    10.9 ASPIVIX
        10.9.1 ASPIVIX Company Information
        10.9.2 ASPIVIX Introduction and Business Overview
        10.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.9.5 ASPIVIX Recent Development
    10.10 Shanghai Dahua Pharmaceuticals
        10.10.1 Shanghai Dahua Pharmaceuticals Company Information
        10.10.2 Shanghai Dahua Pharmaceuticals Introduction and Business Overview
        10.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.10.5 Shanghai Dahua Pharmaceuticals Recent Development
    10.11 Williams Medical Supplies
        10.11.1 Williams Medical Supplies Company Information
        10.11.2 Williams Medical Supplies Introduction and Business Overview
        10.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.11.5 Williams Medical Supplies Recent Development
    10.12 Laboratoire 7 MED
        10.12.1 Laboratoire 7 MED Company Information
        10.12.2 Laboratoire 7 MED Introduction and Business Overview
        10.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.12.5 Laboratoire 7 MED Recent Development
    10.13 Durbin
        10.13.1 Durbin Company Information
        10.13.2 Durbin Introduction and Business Overview
        10.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.13.5 Durbin Recent Development
    10.14 Laboratoire CCD
        10.14.1 Laboratoire CCD Company Information
        10.14.2 Laboratoire CCD Introduction and Business Overview
        10.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.14.5 Laboratoire CCD Recent Development
    10.15 Prosan
        10.15.1 Prosan Company Information
        10.15.2 Prosan Introduction and Business Overview
        10.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.15.5 Prosan Recent Development
    10.16 OCON
        10.16.1 OCON Company Information
        10.16.2 OCON Introduction and Business Overview
        10.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
        10.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Products Offered
        10.16.5 OCON Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Long-acting Reversible Contraceptives (LARCs) Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Long-acting Reversible Contraceptives (LARCs) Industrial Chain Analysis
    11.4 Long-acting Reversible Contraceptives (LARCs) Market Dynamics
        11.4.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
        11.4.2 Long-acting Reversible Contraceptives (LARCs) Market Drivers
        11.4.3 Long-acting Reversible Contraceptives (LARCs) Market Challenges
        11.4.4 Long-acting Reversible Contraceptives (LARCs) Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Long-acting Reversible Contraceptives (LARCs) Distributors
    12.3 Long-acting Reversible Contraceptives (LARCs) Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of Hormonal Intrauterine Devices
    Table 2. Major Company of Copper Intrauterine Devices
    Table 3. Major Company of Contraceptive Implants
    Table 4. Major Company of Others
    Table 5. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (K Units)
    Table 7. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type (2018-2023)
    Table 8. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US& Million)
    Table 9. Global Long-acting Reversible Contraceptives (LARCs) Market Share in Value by Type (2018-2023)
    Table 10. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2018-2023) & (US$/Unit)
    Table 11. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2024-2029) & (K Units)
    Table 12. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type (2024-2029)
    Table 13. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2024-2029) & (US$ Million)
    Table 14. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type (2024-2029)
    Table 15. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2024-2029) & (US$/Unit)
    Table 16. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (K Units)
    Table 17. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US$ Million)
    Table 18. Europe Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Type (2018-2023)
    Table 19. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US$ Million)
    Table 20. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Type (2018-2023)
    Table 21. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US$ Million)
    Table 22. Latin America Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Type (2018-2023)
    Table 23. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US$ Million)
    Table 24. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Type (2018-2023)
    Table 25. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US$ Million)
    Table 26. Global Long-acting Reversible Contraceptives (LARCs) Sales by Company (2018-2023) & (K Units)
    Table 27. Global Long-acting Reversible Contraceptives (LARCs) Sales Share by Company (2018-2023)
    Table 28. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Company (2018-2023) & (US$ Million)
    Table 29. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Company (2018-2023)
    Table 30. Global Market Long-acting Reversible Contraceptives (LARCs) Price by Company (2018-2023) & (US$/Unit)
    Table 31. Global Long-acting Reversible Contraceptives (LARCs) Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 32. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-acting Reversible Contraceptives (LARCs) as of 2022)
    Table 34. Date of Key Manufacturers Enter into Long-acting Reversible Contraceptives (LARCs) Market
    Table 35. Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Type
    Table 36. Mergers & Acquisitions, Expansion Plans
    Table 37. Global Long-acting Reversible Contraceptives (LARCs) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2018-2023) & (K Units)
    Table 39. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Region (2018-2023)
    Table 40. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2018-2023) & (US$ Million)
    Table 41. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Region (2018-2023)
    Table 42. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 43. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2024-2029) & (K Units)
    Table 44. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Region (2024-2029)
    Table 45. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2024-2029) & (US$ Million)
    Table 46. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Region (2024-2029)
    Table 47. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
    Table 48. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 49. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (K Units)
    Table 50. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application (2018-2023)
    Table 51. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
    Table 52. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application (2018-2023)
    Table 53. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2018-2023) & (US$/Unit)
    Table 54. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2024-2029) & (K Units)
    Table 55. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application (2024-2029)
    Table 56. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2024-2029) & (US$ Million)
    Table 57. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application (2024-2029)
    Table 58. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2024-2029) & (US$/Unit)
    Table 59. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) (K Units) 
    Table 60. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
    Table 61. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) (K Units) 
    Table 62. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
    Table 63. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) (K Units) 
    Table 64. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
    Table 65. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) (K Units) 
    Table 66. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
    Table 67. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) (K Units) 
    Table 68. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
    Table 69. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (K Units)
    Table 70. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2018-2023)
    Table 71. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (US$ Million)
    Table 72. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2018-2023)
    Table 73. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (K Units)
    Table 74. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2024-2029)
    Table 75. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (US$ Million)
    Table 76. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2024-2029)
    Table 77. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (K Units)
    Table 78. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2018-2023)
    Table 79. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (US$ Million)
    Table 80. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2018-2023)
    Table 81. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (K Units)
    Table 82. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2024-2029)
    Table 83. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (US$ Million)
    Table 84. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2024-2029)
    Table 85. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2018-2023) & (K Units)
    Table 86. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Region (2018-2023)
    Table 87. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2018-2023) & (US$ Million)
    Table 88. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Region (2018-2023)
    Table 89. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2024-2029) & (K Units)
    Table 90. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Region (2024-2029)
    Table 91. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2024-2029) & (US$ Million)
    Table 92. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Region (2024-2029)
    Table 93. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (K Units)
    Table 94. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2018-2023)
    Table 95. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (US$ Million)
    Table 96. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2018-2023)
    Table 97. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (K Units)
    Table 98. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2024-2029)
    Table 99. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (US$ Million)
    Table 100. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2024-2029)
    Table 101. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (K Units)
    Table 102. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2018-2023)
    Table 103. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (US$ Million)
    Table 104. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2018-2023)
    Table 105. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (K Units)
    Table 106. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2024-2029)
    Table 107. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (US$ Million)
    Table 108. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2024-2029)
    Table 109. Bayer Company Information
    Table 110. Bayer Introduction and Business Overview
    Table 111. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 112. Bayer Long-acting Reversible Contraceptives (LARCs) Product
    Table 113. Bayer Recent Development
    Table 114. Merck Company Information
    Table 115. Merck Introduction and Business Overview
    Table 116. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 117. Merck Long-acting Reversible Contraceptives (LARCs) Product
    Table 118. Merck Recent Development
    Table 119. Cooper Companies Company Information
    Table 120. Cooper Companies Introduction and Business Overview
    Table 121. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 122. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product
    Table 123. Cooper Companies Recent Development
    Table 124. AbbVie Allergan Company Information
    Table 125. AbbVie Allergan Introduction and Business Overview
    Table 126. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 127. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product
    Table 128. AbbVie Allergan Recent Development
    Table 129. Yantai JiShengYaoXie Company Information
    Table 130. Yantai JiShengYaoXie Introduction and Business Overview
    Table 131. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 132. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product
    Table 133. Yantai JiShengYaoXie Recent Development
    Table 134. H & J Medical Company Information
    Table 135. H & J Medical Introduction and Business Overview
    Table 136. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 137. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product
    Table 138. H & J Medical Recent Development
    Table 139. HRA Pharma Company Information
    Table 140. HRA Pharma Introduction and Business Overview
    Table 141. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 142. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product
    Table 143. HRA Pharma Recent Development
    Table 144. Pregna Company Information
    Table 145. Pregna Introduction and Business Overview
    Table 146. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 147. Pregna Long-acting Reversible Contraceptives (LARCs) Product
    Table 148. Pregna Recent Development
    Table 149. ASPIVIX Company Information
    Table 150. ASPIVIX Introduction and Business Overview
    Table 151. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 152. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product
    Table 153. ASPIVIX Recent Development
    Table 154. Shanghai Dahua Pharmaceuticals Company Information
    Table 155. Shanghai Dahua Pharmaceuticals Introduction and Business Overview
    Table 156. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 157. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product
    Table 158. Shanghai Dahua Pharmaceuticals Recent Development
    Table 159. Williams Medical Supplies Company Information
    Table 160. Williams Medical Supplies Introduction and Business Overview
    Table 161. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 162. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product
    Table 163. Williams Medical Supplies Recent Development
    Table 164. Laboratoire 7 MED Company Information
    Table 165. Laboratoire 7 MED Introduction and Business Overview
    Table 166. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 167. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product
    Table 168. Laboratoire 7 MED Recent Development
    Table 169. Durbin Company Information
    Table 170. Durbin Introduction and Business Overview
    Table 171. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 172. Durbin Long-acting Reversible Contraceptives (LARCs) Product
    Table 173. Durbin Recent Development
    Table 174. Laboratoire CCD Company Information
    Table 175. Laboratoire CCD Introduction and Business Overview
    Table 176. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 177. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product
    Table 178. Laboratoire CCD Recent Development
    Table 179. Prosan Company Information
    Table 180. Prosan Introduction and Business Overview
    Table 181. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 182. Prosan Long-acting Reversible Contraceptives (LARCs) Product
    Table 183. Prosan Recent Development
    Table 184. OCON Company Information
    Table 185. OCON Introduction and Business Overview
    Table 186. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 187. OCON Long-acting Reversible Contraceptives (LARCs) Product
    Table 188. OCON Recent Development
    Table 189. Key Raw Materials Lists
    Table 190. Raw Materials Key Suppliers Lists
    Table 191. Long-acting Reversible Contraceptives (LARCs) Market Trends
    Table 192. Long-acting Reversible Contraceptives (LARCs) Market Drivers
    Table 193. Long-acting Reversible Contraceptives (LARCs) Market Challenges
    Table 194. Long-acting Reversible Contraceptives (LARCs) Market Restraints
    Table 195. Long-acting Reversible Contraceptives (LARCs) Distributors List
    Table 196. Long-acting Reversible Contraceptives (LARCs) Downstream Customers
    Table 197. Research Programs/Design for This Report
    Table 198. Key Data Information from Secondary Sources
    Table 199. Key Data Information from Primary Sources
List of Figures
    Figure 1. Long-acting Reversible Contraceptives (LARCs) Product Picture
    Figure 2. Global Long-acting Reversible Contraceptives (LARCs) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Long-acting Reversible Contraceptives (LARCs) Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Hormonal Intrauterine Devices
    Figure 6. Global Hormonal Intrauterine Devices Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Copper Intrauterine Devices
    Figure 8. Global Copper Intrauterine Devices Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of Contraceptive Implants
    Figure 10. Global Contraceptive Implants Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Product Picture of Others
    Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2029) & (US$ Million)
    Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type in 2022 & 2029
    Figure 15. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2022
    Figure 16. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2022
    Figure 17. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2022
    Figure 18. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2022
    Figure 19. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2022
    Figure 20. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2022
    Figure 21. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2022
    Figure 22. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2022
    Figure 23. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2022
    Figure 24. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2022
    Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-acting Reversible Contraceptives (LARCs) Sales in 2022
    Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-acting Reversible Contraceptives (LARCs) Revenue in 2022
    Figure 27. Long-acting Reversible Contraceptives (LARCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 28. Product Picture of Age 20-24
    Figure 29. Global Age 20-24 Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Product Picture of Age 25-34
    Figure 31. Global Age 25-34 Sales YoY Growth (2018-2029) & (K Units)
    Figure 32. Product Picture of Age 35-44
    Figure 33. Global Age 35-44 Sales YoY Growth (2018-2029) & (K Units)
    Figure 34. Product Picture of Others
    Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 36. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2029) & (US$ Million)
    Figure 37. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application in 2022 & 2029
    Figure 38. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2022
    Figure 39. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2022
    Figure 40. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2022
    Figure 41. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2022
    Figure 42. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2022
    Figure 43. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2022
    Figure 44. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2022
    Figure 45. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2022
    Figure 46. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2022
    Figure 47. Key Raw Materials Price
    Figure 48. Long-acting Reversible Contraceptives (LARCs) Manufacturing Cost Structure
    Figure 49. Long-acting Reversible Contraceptives (LARCs) Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed

Long-acting Reversible Contraceptives (LARCs) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Long-acting Reversible Contraceptives (LARCs) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Age 20-24 and Age 25-34 are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Long-acting Reversible Contraceptives (LARCs) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.

Globally, Long-acting Reversible Contraceptives (LARCs) key manufacturers include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna and ASPIVIX, etc. Bayer, Merck, Cooper Companies are top 3 players and held % sales share in total in 2022.

Long-acting Reversible Contraceptives (LARCs) can be divided into Hormonal Intrauterine Devices, Copper Intrauterine Devices, Contraceptive Implants and Others, etc. Hormonal Intrauterine Devices is the mainstream product in the market, accounting for % sales share globally in 2022.

Long-acting Reversible Contraceptives (LARCs) is widely used in various fields, such as Age 20-24, Age 25-34, Age 35-44 and Others, etc. Age 20-24 provides greatest supports to the Long-acting Reversible Contraceptives (LARCs) industry development. In 2022, global % sales of Long-acting Reversible Contraceptives (LARCs) went into Age 20-24 filed. 
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Long-acting Reversible Contraceptives (LARCs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
    Bayer
    Merck
    Cooper Companies
    AbbVie Allergan
    Yantai JiShengYaoXie
    H & J Medical
    HRA Pharma
    Pregna
    ASPIVIX
    Shanghai Dahua Pharmaceuticals
    Williams Medical Supplies
    Laboratoire 7 MED
    Durbin
    Laboratoire CCD
    Prosan
    OCON

Segment by Type
    Hormonal Intrauterine Devices
    Copper Intrauterine Devices
    Contraceptive Implants
    Others

Segment by Application
    Age 20-24
    Age 25-34
    Age 35-44
    Others

Segment by Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E

Each chapter of the report provides detailed information for readers to understand the Long-acting Reversible Contraceptives (LARCs) market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Long-acting Reversible Contraceptives (LARCs), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Long-acting Reversible Contraceptives (LARCs) industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Long-acting Reversible Contraceptives (LARCs) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Long-acting Reversible Contraceptives (LARCs) introduction, etc. Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Long-acting Reversible Contraceptives (LARCs) market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

Industry: Medical Devices & Consumables

Published: 2023-05-31

Pages: 116 Pages

Report ld: 1353800

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License

USD 5025.00

Corporate Users License